Tempest Therapeutics (TPST)
NASDAQ:TPST
Holding TPST?
Track your performance easily

Tempest Therapeutics (TPST) Financial Statements

961 Followers

Tempest Therapeutics Financial Overview

Tempest Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.608; its P/E ratio is -0.84; Tempest Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -9.20M$ -7.54M$ -6.41M$ -7.23M$ -7.29M
EBITDA$ -9.04M$ -7.45M$ -6.33M$ -7.14M$ -7.17M
Net Income Common Stockholders$ -9.57M$ -7.90M$ -6.79M$ -7.58M$ -7.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 31.10M$ 32.30M$ 11.10M$ 17.60M$ 23.35M
Total Assets$ 42.17M$ 44.38M$ 23.99M$ 30.74M$ 37.33M
Total Debt$ 20.25M$ 20.37M$ 21.01M$ 21.48M$ 21.66M
Net Debt$ -10.85M$ -11.93M$ 9.91M$ 3.88M$ -1.69M
Total Liabilities$ 25.23M$ 23.75M$ 25.18M$ 25.73M$ 26.36M
Stockholders Equity$ 16.94M$ 20.63M$ -1.19M$ 5.01M$ 10.96M
Cash Flow-
Free Cash Flow$ -5.76M$ -7.35M$ -6.49M$ -6.51M$ -8.35M
Operating Cash Flow$ -5.51M$ -7.19M$ -6.49M$ -6.39M$ -8.30M
Investing Cash Flow$ -249.00K$ -168.00K-$ -117.00K$ -46.00K
Financing Cash Flow$ 4.56M$ 450.00K$ 21.00K$ 1.19M$ 44.00K
Currency in USD

Tempest Therapeutics Earnings and Revenue History

Tempest Therapeutics Debt to Assets

Tempest Therapeutics Cash Flow

Tempest Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis